Human Recombinant CDKL2 protein, His Tag (V2LY-0526-LY3066)

Yi, R., Yang, S., Liao, Y., Hu, Z., Long, H., Zeng, Y., ... & Wu, Z. (2020). Decreased CDKL2 expression is correlated with the progression and poor prognosis of glioma. Pathology-Research and Practice, 216(5), 152920.

Shao, Q., Wang, F., Xu, Y., Zhang, X., Tang, W., Feng, Y., & Li, Y. (2020). CDKL2 Is Associated with HER2 Status and Overall Survival in Gastric Cancer: Comparative Analysis of CDKL2 Protein Expression and Gene Copy Number. BioMed Research International, 2020.

Zhou, Y., Qiu, X. P., Li, Z. H., Zhang, S., Rong, Y., & Yang, G. H. (2019). Clinical significance of aberrant cyclin-dependent kinase-like 2 methylation in hepatocellular carcinoma. Gene, 683, 35-40.

Zhao, Y., Yang, J., Liu, Y., Fan, J., & Yang, H. (2019). HSV-2-encoded miRNA-H4 regulates cell cycle progression and Act-D-induced apoptosis in HeLa Cells by targeting CDKL2 and CDKN2A. Virologica Sinica, 34(3), 278-286.

Fang, C. L., Uen, Y. H., Chen, H. K., Hseu, Y. C., Lin, C. C., Hung, S. T., ... & Lin, K. Y. (2018). Loss of cyclin‐dependent kinase‐like 2 predicts poor prognosis in gastric cancer, and its overexpression suppresses cells growth and invasion. Cancer medicine, 7(7), 2993-3002.

Yi, R., Yang, S., Wen, E., Hu, Z., Long, H., Zeng, Y., ... & Song, Y. (2018). Negative nuclear expression of CDKL2 correlates with disease progression and poor prognosis of glioma. International journal of clinical and experimental pathology, 11(2), 712.

Lin, K. Y., & Uen, Y. H. (2017). Loss of CDKL2 expression correlates with differentiation, stage, and poor prognosis of gastric cancer. Annals of Oncology, 28, x12.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols